It has been about a month since the last earnings report for Henry Schein (HSIC). Shares have lost about 3.9% in that time frame, outperforming the S&P 500. Will the recent negative trend continue ...

Zacks Research decreased their Q1 2025 earnings per share (EPS) estimates for Henry Schein in a research note issued to ...

Rating, from 69 to 74. Please watch the video at Investors.com - How To Find The Best IPO Stocks IBD's unique rating tracks share price performance with a 1 (worst) to 99 (best) score. The score shows ...

Feb 25 (Reuters) - Henry Schein (HSIC.O), opens new tab forecast annual profit below Wall Street estimates on Tuesday as the dental and medical products distributor faces tepid demand amid ...

HENRY SCHEIN ($HSIC) is expected to release its quarterly earnings data on Tuesday, February 25th before market open, per Finnhub. Analysts are expecting revenue of ...

Henry Schein, Inc. (NASDAQ:HSIC – Free Report) – Equities research analysts at Leerink Partnrs cut their Q2 2025 earnings estimates for Henry Schein in a research report issued to clients and ...

LCI Sales Growth: 5.5% for the quarter, 6.6% excluding lower PPE sales and COVID test kits. GAAP Operating Margin: 4.86%, a 358 basis point improvement year-over-year. Non-GAAP Operating Margin: 7 ...

Henry Schein (NASDAQ:HSIC) Founded in 1932, Henry Schein (NASDAQ:HSIC) is a distributor of healthcare products and services, offering a broad portfolio of medical, dental, and veterinary supplies.